CN105031651B - 一种酶响应型磁性纳米粒及其制备方法与应用 - Google Patents
一种酶响应型磁性纳米粒及其制备方法与应用 Download PDFInfo
- Publication number
- CN105031651B CN105031651B CN201510550456.XA CN201510550456A CN105031651B CN 105031651 B CN105031651 B CN 105031651B CN 201510550456 A CN201510550456 A CN 201510550456A CN 105031651 B CN105031651 B CN 105031651B
- Authority
- CN
- China
- Prior art keywords
- sediment
- particle
- nano
- dissolved
- ultra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 55
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 55
- 239000002122 magnetic nanoparticle Substances 0.000 title claims abstract description 54
- 230000004044 response Effects 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000012838 magnetic nanoparticle method Methods 0.000 title abstract description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 113
- 239000002086 nanomaterial Substances 0.000 claims abstract description 33
- 239000002105 nanoparticle Substances 0.000 claims abstract description 33
- 108010010803 Gelatin Proteins 0.000 claims abstract description 31
- 239000008273 gelatin Substances 0.000 claims abstract description 31
- 229920000159 gelatin Polymers 0.000 claims abstract description 31
- 235000019322 gelatine Nutrition 0.000 claims abstract description 31
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 16
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 11
- 239000002131 composite material Substances 0.000 claims abstract description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000661 sodium alginate Substances 0.000 claims abstract description 8
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 239000003504 photosensitizing agent Substances 0.000 claims abstract description 4
- 238000000975 co-precipitation Methods 0.000 claims abstract description 3
- 238000005354 coacervation Methods 0.000 claims abstract description 3
- 238000011275 oncology therapy Methods 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims abstract description 3
- 239000013049 sediment Substances 0.000 claims description 59
- 238000003756 stirring Methods 0.000 claims description 39
- 239000003643 water by type Substances 0.000 claims description 35
- -1 oleyl amines Chemical class 0.000 claims description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 206010028980 Neoplasm Diseases 0.000 claims description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- AOJJSUZBOXZQNB-TZSSRYMLSA-N doxorubicine Natural products O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 18
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 16
- 238000005119 centrifugation Methods 0.000 claims description 15
- 238000001291 vacuum drying Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 claims description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 8
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 8
- 239000000908 ammonium hydroxide Substances 0.000 claims description 8
- QNZRVYCYEMYQMD-UHFFFAOYSA-N copper;pentane-2,4-dione Chemical class [Cu].CC(=O)CC(C)=O QNZRVYCYEMYQMD-UHFFFAOYSA-N 0.000 claims description 8
- 229960004679 doxorubicin Drugs 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 8
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 8
- 229910052603 melanterite Inorganic materials 0.000 claims description 8
- 235000001508 sulfur Nutrition 0.000 claims description 8
- 230000002194 synthesizing effect Effects 0.000 claims description 8
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 8
- 239000012498 ultrapure water Substances 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 239000005864 Sulphur Substances 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229940041181 antineoplastic drug Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims 3
- 244000248349 Citrus limon Species 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 150000004781 alginic acids Chemical class 0.000 claims 2
- 239000002244 precipitate Substances 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 238000012377 drug delivery Methods 0.000 abstract description 4
- 230000008685 targeting Effects 0.000 abstract description 4
- 238000000015 thermotherapy Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 9
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 6
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 6
- 102000013382 Gelatinases Human genes 0.000 description 5
- 108010026132 Gelatinases Proteins 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000012738 dissolution medium Substances 0.000 description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 229940009456 adriamycin Drugs 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000002626 targeted therapy Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000007626 photothermal therapy Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- WGYFACNYUJGZQO-UHFFFAOYSA-N aminomethanetriol Chemical compound NC(O)(O)O WGYFACNYUJGZQO-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- OMZSGWSJDCOLKM-UHFFFAOYSA-N copper(II) sulfide Chemical compound [S-2].[Cu+2] OMZSGWSJDCOLKM-UHFFFAOYSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000011807 nanoball Substances 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510550456.XA CN105031651B (zh) | 2015-09-01 | 2015-09-01 | 一种酶响应型磁性纳米粒及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510550456.XA CN105031651B (zh) | 2015-09-01 | 2015-09-01 | 一种酶响应型磁性纳米粒及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105031651A CN105031651A (zh) | 2015-11-11 |
CN105031651B true CN105031651B (zh) | 2018-05-15 |
Family
ID=54439004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510550456.XA Active CN105031651B (zh) | 2015-09-01 | 2015-09-01 | 一种酶响应型磁性纳米粒及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105031651B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105477632B (zh) * | 2015-12-09 | 2018-06-26 | 上海师范大学 | Fe3O4/Cu2-xS/Au核壳结构的纳米材料及制备方法 |
CN107303286B (zh) * | 2016-04-14 | 2022-09-30 | 华东理工大学 | 一种明胶杂化复合物及其制备方法和应用 |
CN107007875B (zh) * | 2017-03-29 | 2020-09-22 | 中国人民解放军军事医学科学院野战输血研究所 | 一种酶与温度双响应性载药水凝胶及其制备方法与应用 |
CN111671769B (zh) * | 2020-05-26 | 2023-02-28 | 赣南医学院 | 含铜铁氧体纳米粒子在制备抗肿瘤药物中的应用 |
CN113134012B (zh) * | 2021-03-04 | 2022-11-18 | 江苏大学 | 一种CaO2/Fe3O4@OA纳米复合物及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1732900A (zh) * | 2005-08-31 | 2006-02-15 | 罗聪 | 具有药物控释功能生物活性的植入体、其控释方法和制备方法 |
CN1783363A (zh) * | 2004-12-02 | 2006-06-07 | 北京大学 | 四氧化三铁磁流体及其制备方法和应用 |
-
2015
- 2015-09-01 CN CN201510550456.XA patent/CN105031651B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1783363A (zh) * | 2004-12-02 | 2006-06-07 | 北京大学 | 四氧化三铁磁流体及其制备方法和应用 |
CN1732900A (zh) * | 2005-08-31 | 2006-02-15 | 罗聪 | 具有药物控释功能生物活性的植入体、其控释方法和制备方法 |
Non-Patent Citations (1)
Title |
---|
Sub-10 nm Fe3O4@Cu2−xS Core−Shell Nanoparticles for Dual-Modal Imaging and Photothermal Therapy;Qiwei Tian et al.;《J. Am. Chem. Soc.》;20130520;第135卷;第8571-8577页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105031651A (zh) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105031651B (zh) | 一种酶响应型磁性纳米粒及其制备方法与应用 | |
Pan et al. | Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework | |
Chen et al. | NIR-II light activated photodynamic therapy with protein-capped gold nanoclusters | |
Shen et al. | pH-responsive aerobic nanoparticles for effective photodynamic therapy | |
Song et al. | Donor-acceptor structured photothermal COFs for enhanced starvation therapy | |
Li et al. | Black phosphorus nanophototherapeutics with enhanced stability and safety for breast cancer treatment | |
CN107875158A (zh) | 一种兼具化疗/光治疗的无载体纳米药物的制备方法 | |
Solak et al. | Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells | |
CN111297830B (zh) | 一种介导光疗的分级靶向纳米粒及其制备方法和应用 | |
CN105126113B (zh) | 一种转铁蛋白修饰的中空介孔硫化铜/青蒿琥酯纳米粒的制备方法及其应用 | |
CN108178803B (zh) | 一种载药的肉桂醛-葡聚糖聚合物自组装纳米粒的制备及其抗肿瘤应用 | |
CN108354913A (zh) | 一种纳米载药纳米系统在制备治疗难治性甲状腺癌的药物中的应用 | |
Hu et al. | Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis | |
Yang et al. | Design of the tumor microenvironment-multiresponsive nanoplatform for dual-targeting and photothermal imaging guided photothermal/photodynamic/chemodynamic cancer therapies with hypoxia improvement and GSH depletion | |
Duan et al. | pH-responsive and sustained release drug delivery system of BSA coated CDs-DOX | |
Zhang et al. | Research progress in the synthesis and biological application of quantum dots | |
CN103611172B (zh) | 载纳米雄黄磁性白蛋白纳米球及制备方法 | |
Jiang et al. | O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tumor microenvironment | |
Zheng et al. | Self-polymerized polydopamine-based nanoparticles for acute kidney injury treatment through inhibiting oxidative damages and inflammatory | |
Xia et al. | Near-infrared organic fluorescent nanoparticles for long-term monitoring and photodynamic therapy of cancer | |
CN105056234B (zh) | 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 | |
CN109091674A (zh) | 一种多功能药物载体及其制备方法与应用 | |
Yang et al. | Ferrocene-based multifunctional nanoparticles for combined chemo/chemodynamic/photothermal therapy | |
Wang et al. | Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment | |
Zeng et al. | Highly efficient Chemo/Photothermal therapy alleviating tumor hypoxia against cancer and attenuate liver metastasis in vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhenzhong Inventor after: Zhu Xiali Inventor after: Huang Heqing Inventor after: Zhang Yingjie Inventor after: Hou Lin Inventor after: Zhang Huijuan Inventor after: Li Hongji Inventor before: Zhu Xiali Inventor before: Huang Heqing Inventor before: Zhang Zhenzhong Inventor before: Zhang Yingjie Inventor before: Hou Lin Inventor before: Zhang Huijuan Inventor before: Li Hongji |
|
COR | Change of bibliographic data | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 450001 Zhengzhou science and Technology Development Zone, Henan, No. 100 science Avenue Applicant after: Zhengzhou University Address before: 450001 science avenue of Zhengzhou high tech Development Zone, Zhengzhou, Henan Province, No. Applicant before: Zhengzhou University |
|
GR01 | Patent grant | ||
GR01 | Patent grant |